Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study
Christian Leonardo Molina-Hinojosa, Ramón Carreras-Collado, María Saumoy-Linares, Judith Peñafiel, Fatima Heydari, Joan Climent Martí, María Eulalia Fernández-Montolí · 2026
Read Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study by Christian Leonardo Molina-Hinojosa, Ramón Carreras-Collado, María Saumoy-Linares, Judith Peñafiel, Fatima Heydari, Joan Climent Martí, María Eulalia Fernández-Montolí (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13255978.txt.
Description
Christian Leonardo Molina-Hinojosa and co-authors report a 2026 twenty-year cohort study from a Barcelona hospital on cervical precancer coming back after treatment. Women treated with a loop excision for high-grade lesions (CIN 2-3) were followed, setting those with weakened immunity, many living with HIV, against women with intact immunity.
Leftover or returning disease struck about a third of women with weak immunity, versus under five percent of the comparison group. Recurrences also came sooner, at a median of seven months against thirteen. Lasting high-risk HPV infection and cancer cells at the cut edge were the factors tied most strongly to relapse. Weaker immune markers tracked with earlier relapse in early analysis. The authors argue for personal, tighter follow-up that joins gynecology, infectious disease care, and immune checks.
Catalog record
| CREATOR | Christian Leonardo Molina-Hinojosa, Ramón Carreras-Collado, María Saumoy-Linares, Judith Peñafiel, Fatima Heydari, Joan Climent Martí, María Eulalia Fernández-Montolí |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |